Characteristics of a stable and satisfactory condition in long term survivors of pulmonary arterial hypertension

M. van de Veerdonk, T. Marcus, F. de Man, H. J. Bogaard, A. Boonstra, N. Westerhof, A. Vonk Noordegraaf (Amsterdam, Netherlands)

Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Session: Pulmonary circulation: clinical pulmonary hypertension I
Session type: Thematic Poster Session
Number: 2628
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. van de Veerdonk, T. Marcus, F. de Man, H. J. Bogaard, A. Boonstra, N. Westerhof, A. Vonk Noordegraaf (Amsterdam, Netherlands). Characteristics of a stable and satisfactory condition in long term survivors of pulmonary arterial hypertension. Eur Respir J 2013; 42: Suppl. 57, 2628

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Variation in mortality from pulmonary hypertension by aetiology
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Clinical meaning of low DLCO in idiopathic pulmonary arterial hypertension (IPAH) - Prospective single centre study
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015

Investigation of balance deficits in patients with pulmonary arterial hypertension: Preliminary study
Source: International Congress 2015 – Physiotherapy assessment and techniques in pulmonary and non-pulmonary conditions
Year: 2015

An epidemiological study of pulmonary arterial hypertension in Japan
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015


Time course of pulmonary artery pressure and clinical characteristics in Kyrgyz highlanders
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Pulmonary hypertension due to lung disease – Results from COMPERA
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015

Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Pulmonary function is associated with pulmonary artery systolic pressure in the general population: The Rotterdam study
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013

Change of right heart size and function by long-term therapy with riociguat in patients with PAH and CTEPH
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Pulmonary arterial hypertension patients underrepresented in clinical trials – Are they different?
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016

Pulmonary arterial hypertension: genetics, reversibility testing and follow-up
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=33
Year: 2004

The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 589-596
Year: 2012



Myocardial perfusion in patients with pulmonary hypertension of different etiology
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015


Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015

About cardiac output assessment in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: The multicenter cross-sectional ACHILLE study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
Source: Eur Respir J, 50 (1) 1700217; 10.1183/13993003.00217-2017
Year: 2017



Screening pulmonary hypertension by lung doppler signal: A proof-of-concept study
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015